Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00564486 · ClinicalTrials.gov registry record · Phase 3
Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain
A Phase 3 study of Pain, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 3
- Development phase
- 244
- Enrollment target
- 17
- Study locations
NCT00564486 is a Phase 3 study of Pain that has completed, run by Mallinckrodt. The registered enrollment target is 244 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (20% lower). The trial reports 17 study locations across 8 states.
The verdict
NCT00564486, a Phase 3 study of Pain, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 244 participants
- Enrollment target
- 17
- Study locations
Study Summary
This research study will look at the pain relieving ability and safety of using repeated doses of intravenous (into the vein \[IV\]) acetaminophen in the treatment of moderate postoperative pain after planned or elective abdominal laparoscopic surgery, such as a laparoscopic abdominal hysterectomy or laparoscopic cholecystectomy (removal of the gall bladder).
Conditions Studied
Interventions
- DRUG IV Placebo
- DRUG IV Acetaminophen
Study Locations (17)
Florida
- Visions Clinical Research - Boynton Beach
- Nature Coast Clinical Research - Crystal River
- G and G Research, Inc. - Ft. Pierce
- Advanced Surgery Associates at Mercy Hospital - Miami
- University of Miami School of Medicine - Miami
California
- Methodist Hospital - Arcadia
- Glendale Adventist Medical Center - Glendale
- Physicians Clinical Research Corporation - Laguna Hills
- Huntington Memorial Hospital - Pasadena
Michigan
- William Beaumont Hospital (Royal Oak) - Royal Oak
- William Beaumont Hospital (Troy) - Royal Oak
Texas
- Memorial Herman/Memorial City Hospital - Houston
- Texas Woman's Hospital - Houston
Alabama
- Helen Keller Hospital - Sheffield
Arizona
- Precision Trials - Phoenix
New Jersey
- Cooper University Hospital - Camden
New York
- Staten Island University Hospital - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00564486
The ClinicalTrials.gov registry entry for NCT00564486 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (20% lower). The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which IV Placebo is the first listed.
NCT00564486 reports 17 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT00564486 about?
NCT00564486 is a clinical study titled "Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain". This research study will look at the pain relieving ability and safety of using repeated doses of intravenous (into the vein \[IV\]) acetaminophen in the treatment of moderate postoperative pain after planned or elective abdominal laparoscopic surgery, such as a laparoscopic abdominal hysterectomy o...
What is the current status of trial NCT00564486?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 244 participants. The study started on 2007-11. Estimated completion is 2008-09.
What conditions does trial NCT00564486 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00564486?
The interventions under investigation include: IV Placebo (DRUG), IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT00564486?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00564486 being conducted?
This trial has 17 study locations across Alabama, Arizona, California, Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.